Prostate Cancer
Precision intervention for prostate cancer: Re-evaluating who is at risk.
September 28, 2023
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.
September 28, 2023
Docetaxel radiosensitizes castration resistant prostate cancer by downregulating CAV-1.
September 27, 2023
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis.
September 27, 2023
Low-Value Prostate Cancer Screening Among Young Men With Private Insurance.
September 27, 2023
Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy.
September 27, 2023
Rare Genetic Drivers of Lethal Prostate Cancer.
September 26, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
September 26, 2023
Practical Guidance on [177Lu]Lu-PSMA-617 Treatment, Including Radiation Safety, Adverse Event Monitoring, and Patient Counseling.
September 26, 2023
Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol.
September 26, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
September 25, 2023
Development and evaluation of the MiCheckĀ® Prostate test for clinically significant prostate cancer.
September 25, 2023